申请人:Li Tong-Shuang
公开号:US20130131044A1
公开(公告)日:2013-05-23
The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
该发明提供了式(I)的化合物,用于选择性地抑制糖苷酶,该化合物的前药以及包括该化合物或该化合物的前药的药物组合物。该发明还提供了治疗与O-GlcNAcase缺乏或过度表达,O-GlcNAc的积累或缺乏相关的疾病和疾病的方法。